Surgery Partners, Inc. (NASDAQ:SGRY) CFO David T. Doherty Sells 6,733 Shares of Stock

Surgery Partners, Inc. (NASDAQ:SGRYGet Free Report) CFO David T. Doherty sold 6,733 shares of Surgery Partners stock in a transaction on Monday, March 10th. The stock was sold at an average price of $24.02, for a total transaction of $161,726.66. Following the transaction, the chief financial officer now directly owns 150,868 shares of the company’s stock, valued at approximately $3,623,849.36. This trade represents a 4.27 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

Surgery Partners Stock Up 0.9 %

Shares of NASDAQ SGRY opened at $23.61 on Friday. The stock has a 50-day moving average price of $23.53 and a two-hundred day moving average price of $26.14. Surgery Partners, Inc. has a 12 month low of $19.50 and a 12 month high of $33.97. The company has a current ratio of 1.80, a quick ratio of 1.66 and a debt-to-equity ratio of 0.99. The company has a market cap of $3.01 billion, a price-to-earnings ratio of -49.19, a PEG ratio of 19.21 and a beta of 2.73.

Surgery Partners (NASDAQ:SGRYGet Free Report) last announced its quarterly earnings results on Monday, March 3rd. The company reported $0.39 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.38 by $0.01. Surgery Partners had a negative net margin of 2.03% and a positive return on equity of 2.85%. The company had revenue of $864.40 million during the quarter, compared to the consensus estimate of $828.09 million. As a group, analysts forecast that Surgery Partners, Inc. will post 0.67 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several research firms have recently commented on SGRY. Royal Bank of Canada decreased their target price on Surgery Partners from $49.00 to $35.00 and set an “outperform” rating on the stock in a research report on Wednesday, November 20th. JPMorgan Chase & Co. dropped their price objective on shares of Surgery Partners from $38.00 to $28.00 and set a “neutral” rating for the company in a research note on Tuesday, December 3rd. Bank of America began coverage on shares of Surgery Partners in a research report on Monday, December 16th. They set a “buy” rating and a $30.00 target price on the stock. Finally, Macquarie dropped their price target on shares of Surgery Partners from $34.00 to $33.00 and set an “outperform” rating for the company in a research report on Tuesday. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and seven have given a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $36.63.

Get Our Latest Stock Report on Surgery Partners

Hedge Funds Weigh In On Surgery Partners

Several large investors have recently bought and sold shares of SGRY. Principal Financial Group Inc. acquired a new position in shares of Surgery Partners in the third quarter valued at approximately $1,469,000. State of New Jersey Common Pension Fund D bought a new stake in Surgery Partners during the 3rd quarter worth approximately $1,968,000. Versor Investments LP acquired a new position in Surgery Partners in the 3rd quarter valued at approximately $271,000. Victory Capital Management Inc. raised its stake in shares of Surgery Partners by 140.4% during the third quarter. Victory Capital Management Inc. now owns 1,330,399 shares of the company’s stock valued at $42,892,000 after acquiring an additional 777,038 shares during the last quarter. Finally, KBC Group NV lifted its holdings in shares of Surgery Partners by 31.8% during the third quarter. KBC Group NV now owns 2,385 shares of the company’s stock worth $77,000 after purchasing an additional 576 shares during the period.

Surgery Partners Company Profile

(Get Free Report)

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.

Read More

Insider Buying and Selling by Quarter for Surgery Partners (NASDAQ:SGRY)

Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.